Han‐Shen Tae

1.0k total citations
60 papers, 820 citations indexed

About

Han‐Shen Tae is a scholar working on Molecular Biology, Cellular and Molecular Neuroscience and Organic Chemistry. According to data from OpenAlex, Han‐Shen Tae has authored 60 papers receiving a total of 820 indexed citations (citations by other indexed papers that have themselves been cited), including 60 papers in Molecular Biology, 14 papers in Cellular and Molecular Neuroscience and 5 papers in Organic Chemistry. Recurrent topics in Han‐Shen Tae's work include Nicotinic Acetylcholine Receptors Study (52 papers), Receptor Mechanisms and Signaling (37 papers) and Ion channel regulation and function (30 papers). Han‐Shen Tae is often cited by papers focused on Nicotinic Acetylcholine Receptors Study (52 papers), Receptor Mechanisms and Signaling (37 papers) and Ion channel regulation and function (30 papers). Han‐Shen Tae collaborates with scholars based in Australia, China and United States. Han‐Shen Tae's co-authors include David J. Adams, Rilei Yu, Tao Jiang, Angela F. Dulhunty, Marco G. Casarotto, Philip G. Board, David J. Craik, Yanfang Cui, Yamuna Karunasekara and Hartmut Cuny and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of the American Chemical Society and Journal of Biological Chemistry.

In The Last Decade

Han‐Shen Tae

57 papers receiving 815 citations

Peers

Han‐Shen Tae
Vladimir M. Mahnir United States
Russell W. Teichert United States
Marion Loughnan Australia
Ron C. Hogg Australia
Julie K. Klint Australia
Vladimir M. Mahnir United States
Han‐Shen Tae
Citations per year, relative to Han‐Shen Tae Han‐Shen Tae (= 1×) peers Vladimir M. Mahnir

Countries citing papers authored by Han‐Shen Tae

Since Specialization
Citations

This map shows the geographic impact of Han‐Shen Tae's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Han‐Shen Tae with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Han‐Shen Tae more than expected).

Fields of papers citing papers by Han‐Shen Tae

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Han‐Shen Tae. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Han‐Shen Tae. The network helps show where Han‐Shen Tae may publish in the future.

Co-authorship network of co-authors of Han‐Shen Tae

This figure shows the co-authorship network connecting the top 25 collaborators of Han‐Shen Tae. A scholar is included among the top collaborators of Han‐Shen Tae based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Han‐Shen Tae. Han‐Shen Tae is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Zhang, Yuhui, Han‐Shen Tae, David J. Adams, Thomas Durek, & David J. Craik. (2025). Cyclization of the Analgesic α‐Conotoxin Vc1.1 With a Non‐Natural Linker: Effects on Structure, Stability, and Bioactivity. Journal of Peptide Science. 31(6). e70017–e70017.
2.
Chan, Carmel T., Han‐Shen Tae, Cho Yeow Koh, David J. Adams, & R. Manjunatha Kini. (2025). Erabutoxin mutants demonstrate interface selectivity at human fetal and adult muscle-type nicotinic acetylcholine receptors. Biochemical Pharmacology. 241. 117189–117189.
3.
Tae, Han‐Shen, Marcelo O. Ortells, Arsalan Yousuf, et al.. (2024). Tabernanthalog and ibogainalog inhibit the α7 and α9α10 nicotinic acetylcholine receptors via different mechanisms and with higher potency than the GABAA receptor and CaV2.2 channel. Biochemical Pharmacology. 223. 116183–116183. 3 indexed citations
4.
Finol‐Urdaneta, Rocio K., et al.. (2023). Nicotinic acetylcholine receptors: Key targets for attenuating neurodegenerative diseases. The International Journal of Biochemistry & Cell Biology. 157. 106387–106387. 15 indexed citations
5.
Tae, Han‐Shen & David J. Adams. (2023). Nicotinic acetylcholine receptor subtype expression, function, and pharmacology: Therapeutic potential of α-conotoxins. Pharmacological Research. 191. 106747–106747. 9 indexed citations
6.
Krishnarjuna, Bankala, Jeffrey Seow, Han‐Shen Tae, et al.. (2023). Characterisation of Elevenin-Vc1 from the Venom of Conus victoriae: A Structural Analogue of α-Conotoxins. Marine Drugs. 21(2). 81–81. 4 indexed citations
7.
Wilhelm, Patrick, Karen Luna-Ramírez, Yanni K.‐Y. Chin, et al.. (2022). Cysteine-Rich α-Conotoxin SII Displays Novel Interactions at the Muscle Nicotinic Acetylcholine Receptor. ACS Chemical Neuroscience. 13(8). 1245–1250. 2 indexed citations
8.
Bağdaş, Deniz, Zülfiye Gül, Sinan Çavun, et al.. (2021). (E)-3-furan-2-yl-N-phenylacrylamide (PAM-4) decreases nociception and emotional manifestations of neuropathic pain in mice by α7 nicotinic acetylcholine receptor potentiation. Neurological Research. 43(12). 1056–1068. 10 indexed citations
9.
Torres, Joshua P., Zhenjian Lin, Maren Watkins, et al.. (2021). Small-molecule mimicry hunting strategy in the imperial cone snail, Conus imperialis. Science Advances. 7(11). 21 indexed citations
10.
Zheng, Meiling, Han‐Shen Tae, Liang Xue, Tao Jiang, & Rilei Yu. (2021). Mechanism of interactions between α-conotoxin RegIIA and carbohydrates at the human α3β4 nicotinic acetylcholine receptor. Marine Life Science & Technology. 4(1). 98–105. 6 indexed citations
11.
Arias, Hugo R., Han‐Shen Tae, Laura Micheli, et al.. (2020). Coronaridine congeners decrease neuropathic pain in mice and inhibit α9α10 nicotinic acetylcholine receptors and CaV2.2 channels. Neuropharmacology. 175. 108194–108194. 21 indexed citations
12.
Li, Xiao, Han‐Shen Tae, Yanyan Chu, et al.. (2020). Medicinal chemistry, pharmacology, and therapeutic potential of α-conotoxins antagonizing the α9α10 nicotinic acetylcholine receptor. Pharmacology & Therapeutics. 222. 107792–107792. 34 indexed citations
13.
Tae, Han‐Shen, et al.. (2018). Stoichiometry dependent inhibition of rat α3β4 nicotinic acetylcholine receptor by the ribbon isomer of α-conotoxin AuIB. Biochemical Pharmacology. 155. 288–297. 8 indexed citations
14.
Durek, Thomas, Irina V. Shelukhina, Han‐Shen Tae, et al.. (2017). Interaction of Synthetic Human SLURP-1 with the Nicotinic Acetylcholine Receptors. Scientific Reports. 7(1). 16606–16606. 17 indexed citations
15.
Huang, Yen‐Hua, Quentin Kaas, Peta J. Harvey, et al.. (2017). Backbone cyclization of analgesic conotoxin GeXIVA facilitates direct folding of the ribbon isomer. Journal of Biological Chemistry. 292(41). 17101–17112. 16 indexed citations
16.
Tae, Han‐Shen, Xinying Jia, Quentin Kaas, et al.. (2017). Role of CysI–CysIII Disulfide Bond on the Structure and Activity of α-Conotoxins at Human Neuronal Nicotinic Acetylcholine Receptors. ACS Omega. 2(8). 4621–4631. 15 indexed citations
17.
Tae, Han‐Shen, Yanfang Cui, Yamuna Karunasekara, et al.. (2011). Cyclization of the Intrinsically Disordered α1S Dihydropyridine Receptor II-III Loop Enhances Secondary Structure and in Vitro Function. Journal of Biological Chemistry. 286(25). 22589–22599. 13 indexed citations
18.
Tae, Han‐Shen, Lan Wei, Esther M. Gallant, et al.. (2011). The elusive role of the SPRY2 domain in RyR1. Channels. 5(2). 148–160. 13 indexed citations
19.
Tae, Han‐Shen, Marco G. Casarotto, & Angela F. Dulhunty. (2009). Ubiquitous SPRY domains and their role in the skeletal type ryanodine receptor. European Biophysics Journal. 39(1). 51–59. 23 indexed citations
20.
Cui, Yanfang, Han‐Shen Tae, Yamuna Karunasekara, et al.. (2008). A dihydropyridine receptor α1s loop region critical for skeletal muscle contraction is intrinsically unstructured and binds to a SPRY domain of the type 1 ryanodine receptor. The International Journal of Biochemistry & Cell Biology. 41(3). 677–686. 44 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026